Partners In Practice Articles
Between February 6, 2014 and March 15, 2014 a total of 529 physicians, nurse practitioners, physician assistants, nurses, pharmacists and medical students participated in the online CME activity “Optimizing Dose Intensity for Patients with Metastatic Renal Cell Carcinoma.”
The management of hepatocellular carcinoma (HCC) requires a careful multidisciplinary approach utilizing medical oncologists, surgeons and interventional radiologists. Treatment options require assessment of tumor stage, liver function and performance status.
by Boris Kuvshinoff II, MD, MBA
Chief Medical Officer, Professor of Oncology
Pancreatic cancer is a highly desmoplastic disease. Microscopically, the nests of cancer cells are surrounded by thick and abundant stromal tissue that is constituted by collagen, fibroblasts, stellate cells, inflammatory infiltrate and endothelial cells.
Steven Hochwald, MD, FACS, Chief of Gastrointestinal Surgery and Vice Chair of Surgical Oncology, explains how our comprehensive, multidisciplinary team approach to treating colorectal cancer helps preserve quality of life for our surgical patients.
Renuka Iyer, MD, Co-Director, Liver and Pancreas Tumor Program and Section Chief for Gastrointestinal Oncology, describes how research and clinical trials are offering renewed hope to patients with metastatic colorectal cancer.